Middletown Life

Author: Kaixing Life Technology (Shanghai) Co., LTD

CARsgen Therapeutics Announces 2025 Annual Results

March 6, 2026
CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in Jinshan, Shanghai

February 13, 2026
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors

January 12, 2026
CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

December 28, 2025
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

December 7, 2025
CARsgen’s CAR-T Product Zevor-Cel Included in China’s Commercial Health Insurance Innovative Drug Catalogue

December 7, 2025